TLR7 and systemic lupus erythematosus: TLR-7 induction with imiquimod, a topical TLR-7 agonist, is the basis of the experimental lupus model in our study: wild-type mice subjected to epicutaneous application of imiquimod cream, three times weekly, developed lupus-like manifestations [19].